About Us

Stephanie Monaghan O’Brien

Stephanie Monaghan O’Brien, J.D.


Stephanie O’Brien represents Morningside Ventures and has extensive experience working with venture-backed companies focused on novel science. She focuses on early-stage companies, working with CEOs on building the management team and developing business plans. She has served on numerous private company boards, including Aduro Biotech, Inc., ViOptiox, Inc., I-Behavior, Inc., Natural Polymer International Corp., Serica Technology, Inc., and BiddingForGood, Inc. She received her A.B., cum laude, from Harvard College and her J.D. from New York University School of Law. Prior to attending law school, Stephanie worked for Chase Manhattan Bank, N.A, where she completed the loan officer credit training program and then worked in international portfolio analysis. After law school, Stephanie spent nine years as a corporate lawyer with Hale and Dorr in the Boston and Washington, D.C. offices, working primarily with venture capital finance and start-up companies.
Apellis logo
© Apellis Pharmaceuticals 2019.